Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cargo Therapeutics Inc (CRGX)

Cargo Therapeutics Inc (CRGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 212,106
  • Shares Outstanding, K 46,110
  • Annual Sales, $ 0 K
  • Annual Income, $ -167,500 K
  • EBIT $ -235 M
  • EBITDA $ -228 M
  • 60-Month Beta 0.28
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.75

Options Overview Details

View History
  • Implied Volatility 83.09% ( -47.06%)
  • Historical Volatility 33.75%
  • IV Percentile 2%
  • IV Rank 4.48%
  • IV High 365.70% on 04/11/25
  • IV Low 69.84% on 12/23/24
  • Put/Call Vol Ratio 0.51
  • Today's Volume 163
  • Volume Avg (30-Day) 356
  • Put/Call OI Ratio 1.83
  • Today's Open Interest 5,864
  • Open Int (30-Day) 2,522

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.38
  • Number of Estimates 4
  • High Estimate -0.01
  • Low Estimate -0.60
  • Prior Year -1.02
  • Growth Rate Est. (year over year) +62.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.07 +12.74%
on 06/26/25
4.75 -3.37%
on 07/08/25
+0.10 (+2.23%)
since 06/11/25
3-Month
3.78 +21.59%
on 05/14/25
4.77 -3.77%
on 04/23/25
+0.33 (+7.75%)
since 04/11/25
52-Week
3.00 +53.00%
on 01/30/25
25.45 -81.96%
on 09/18/24
-12.61 (-73.31%)
since 07/11/24

Most Recent Stories

More News
CARGO Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $4.379 in Cash per Share Plus a Contingent Value Right

CRGX : 4.59 (-0.22%)
CARGO Therapeutics Provides Corporate Update

CRGX : 4.59 (-0.22%)
Retail Traders Flocked To These 5 Biotech Stocks In January — Here’s Why

Biotech remains a high-risk, high-reward sector, and this month’s top draws reflect retail’s appetite for stocks with major clinical and regulatory catalysts.

KAPA : 0.7100 (-0.14%)
SANA : 4.18 (+2.96%)
SLXN : 0.7901 (-4.33%)
AEON : 0.8400 (-2.33%)
CRGX : 4.59 (-0.22%)
CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic Options

CRGX : 4.59 (-0.22%)
CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025

CRGX : 4.59 (-0.22%)
How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

/CNW/ -- USA News Group News Commentary – Recent advancements in cancer treatment continue to underscore the transformative potential of innovative therapies...

ONCY : 1.1800 (+5.83%)
RPTX : 1.5000 (-3.85%)
IMRX : 4.42 (+2.08%)
ONC.TO : 1.60 (+5.96%)
RNXT : 1.2800 (-4.48%)
CRGX : 4.59 (-0.22%)
CARGO Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

CARGO Therapeutics will present at the J.P. Morgan Healthcare Conference on January 13, 2025, in San Francisco.Quiver AI SummaryCARGO Therapeutics, Inc., a clinical-stage biotechnology company focused...

CRGX : 4.59 (-0.22%)
CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

CRGX : 4.59 (-0.22%)
CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

CRGX : 4.59 (-0.22%)
CARGO Therapeutics to Participate in Upcoming Investor Conferences

CRGX : 4.59 (-0.22%)

Business Summary

CARGO Therapeutics Inc. is a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022 and CRG-023. CARGO Therapeutics Inc. is based in San Mateo, California.

See More

Key Turning Points

3rd Resistance Point 4.64
2nd Resistance Point 4.62
1st Resistance Point 4.61
Last Price 4.59
1st Support Level 4.57
2nd Support Level 4.55
3rd Support Level 4.54

See More

52-Week High 25.45
Fibonacci 61.8% 16.87
Fibonacci 50% 14.23
Fibonacci 38.2% 11.58
Last Price 4.59
52-Week Low 3.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar